You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Biliary Tract Carcinoma (BTC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Apr 10, 2023

Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

Not yet recruiting
  • Biliary Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 13, 2023

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Biliary Tract Carcinoma Trial in Shanghai (GP+PD-1+Tight)

Recruiting
  • Biliary Tract Carcinoma
  • Shanghai, China
    Zhongshan hospital
Mar 22, 2022

Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)

Not yet recruiting
  • Biliary Tract Neoplasms
  • Total Neoadjuvant Treatment
  • (no location specified)
Sep 7, 2023

Biliary Tract Tumors, Cholangiocarcinoma, Bile Duct Cancer Trial run by the NCI (Pembrolizumab (MK-3475), Oxaliplatin,

Completed
Has Results
  • Biliary Tract Neoplasms
  • +4 more
  • Pembrolizumab (MK-3475)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 1, 2021

Advanced Primary Liver Cancer, Advanced Biliary Tract Carcinoma Trial in Zhengzhou, Nanjing (SHR-1210, Apatinib, FOLFOX4)

Active, not recruiting
  • Advanced Primary Liver Cancer
  • Advanced Biliary Tract Carcinoma
  • SHR-1210
  • +3 more
  • Zhengzhou, Henan, China
  • +1 more
Apr 26, 2022

Incidental Gallbladder Carcinoma-Permanent Platform Including

Recruiting
  • Biliary Tract Cancer
  • Neoadjuvant, Adjuvant and 1st Line
    • Frankfurt, Germany
      Krankenhaus Nordwest GmbH
    Aug 3, 2022

    Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

    Not yet recruiting
    • Biliary Tract Carcinoma
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Sep 15, 2023

    Biliary Tract Tumors, Liver Cancer, Hepatocellular Carcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Trans-arterial

    Active, not recruiting
    Has Results
    • Biliary Tract Neoplasms
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Mar 1, 2022

    Incidental Gallbladder Carcinoma, Biliary Tract Cancer Trial in Frankfurt (Gemcitabine, Cisplatin, Oncologically radical

    Recruiting
    • Incidental Gallbladder Carcinoma
    • Biliary Tract Cancer
    • Frankfurt, Germany
      Krankenhaus Nordwest gGmbH
    Sep 7, 2022

    Biliary Tract Carcinoma Trial in China (Pembrolizumab, Gemcitabine, Cisplatin)

    Active, not recruiting
    • Biliary Tract Carcinoma
    • Pembrolizumab
    • +3 more
    • Hefei, Anhui, China
    • +21 more
    Aug 16, 2022

    Locally Advanced Biliary Tract Cancer, Metastatic Biliary Tract Cancer Trial in Guangzhou (Camrelizumab and Apatinib Plus GP)

    Not yet recruiting
    • Locally Advanced Biliary Tract Cancer
    • Metastatic Biliary Tract Cancer
    • Camrelizumab and Apatinib Plus GP
    • Guangzhou, Guangdong, China
      Cancer center of SunYat-sen University
    Feb 15, 2023

    Biliary Tract Cancer Trial in Seoul (Pemetrexed 500 MG, Erlotinib)

    Recruiting
    • Biliary Tract Cancer
    • Seoul, Korea, Republic of
    • +1 more
    Jun 13, 2022

    Advanced Biliary Tract Carcinoma Trial in France (Durvalumab, Tremelimumab)

    Recruiting
    • Advanced Biliary Tract Carcinoma
    • Besançon, France
    • +27 more
    Jan 26, 2021

    Biliary Tract Carcinoma Trial in Shanghai (Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab)

    Recruiting
    • Biliary Tract Carcinoma
    • Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Dec 25, 2022

    Advanced Biliary Tract Carcinoma Trial in Shanghai (Pembrolizumab Injection [Keytruda], Lenvatinib Mesylate)

    Recruiting
    • Advanced Biliary Tract Carcinoma
    • Pembrolizumab Injection [Keytruda]
    • Lenvatinib Mesylate
    • Shanghai, Shanghai, China
    • +1 more
    Jul 19, 2022

    Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -

    Not yet recruiting
    • Biliary Tract Cancer
      • (no location specified)
      Apr 26, 2023

      Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

      Not yet recruiting
      • Biliary Tract Cancer
      • Cholangiocarcinoma
      • Ancona, Italy
      • +18 more
      Sep 16, 2023

      Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

      Recruiting
      • Biliary Tract Cancer
      • +2 more
      • Immune Checkpoint Inhibitors
      • Beijing, Beijing, China
        Chinese Academy of Medical Sciences & Peking Union Medical Colle
      Oct 5, 2023

      AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary

      Recruiting
      • Biliary Tract Cancer
      • Blood drawing
      • Guangzhou, Guangdong, China
      • +1 more
      Dec 28, 2022

      Advanced Biliary Tract Cancer Trial in Changsha (IBI310, sintilimab)

      Not yet recruiting
      • Advanced Biliary Tract Cancer
      • Changsha, Hunan, China
        Hunan cancer Hospital
      Dec 13, 2022

      Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • +6 more
      • (no location specified)
      Oct 10, 2023

      Bile cfDNA of Resectable Biliary Tract Carcinomas

      Recruiting
      • This Study Aims to Reveal the Effectiveness, Accuracy, and Feasibility in Bile
      • Next generation sequencing
      • Guangzhou, Guangdong, China
        Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
      Mar 13, 2023

      Biliary Tract Carcinoma Trial in Hershey (Abemaciclib)

      Recruiting
      • Biliary Tract Carcinoma
      • Hershey, Pennsylvania
        Penn State Cancer Institute
      Feb 3, 2022